Welcome to iVRS, a Contract Research Organization (CRO) that offers full-service In-Vitro solutions in Pharmaceutical and Nutraceutical Product Development to Pharmaceutical, Medical Device, and Biotechnology organizations throughout the world. In-Vitro characterization and in vitro bioequivalence of pharmaceutical products are governed by methodical R&D, tight regulatory standards, and quality & compliance. iVRS is comprised of an experienced team with a comprehensive grasp of regulatory requirements in the areas of both Clinical & Non-Clinical. The iVRS team believes in systematic and ongoing training to achieve operational success. The team has prior expertise in planning, executing, and submitting to regulatory bodies analytical (including extractable and leachable, IVRT & IVPT, Feeding tube) & IVBE studies. iVRS aims to include all InVitro techniques used and recommended for various pharmaceutical dosage forms such as oral solid/liquid dosage forms, injectable suspension/solutions, ophthalmic suspensions/solutions/drops, pulmonary aerosols/sprays, dermal products such as ointments/creams/gels, suppositories/vaginal preparations, and so on. iVRS believes in thorough, methodical, and suitable method development, validation, and optimization's of in vitro techniques and analytical techniques. If iVRS adheres to regulatory standards such as good laboratory practices, good clinical practices, good documentation practices, applicable regulatory guidance, ICH guidelines with adherence to quality and compliance, synchronized with R&D, study conduct, and appropriate data presentation, regulatory agencies will review the data more quickly and easily. Show more Show less
2018